The Impact of Genetic Polymorphism on the Echocardiographic Parameters and Cardiac Fibrosis Markers in Response to Empagliflozin Treatment Among Patients With Heart Failure

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

July 30, 2023

Primary Completion Date

July 30, 2025

Study Completion Date

October 1, 2025

Conditions

Heart Failure

Trial Locations (1)

Ain shams university, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER